Related Experiment Video
Updated: Jan 6, 2026

Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis
Published on: June 14, 2024
Sepsis-induced cardiomyopathy
Nadia Aissaoui1, Florence Boissier2, Michelle Chew3
1Department of Cardiology, Georges Pompidou Hospital, Université Paris Cité, 20-25 rue Leblanc, 75015 Paris, France.
Insights
Sepsis-induced cardiomyopathy (SICM) is a common, reversible heart dysfunction in critically ill patients. Understanding SICM
Area of Science:
- Critical Care Medicine
- Cardiology
- Sepsis Research
Background:
- Sepsis is a leading cause of death globally and a frequent diagnosis in CCUs.
- Sepsis-induced cardiomyopathy (SICM) is a recognized cardiac complication of sepsis.
- SICM is characterized by reversible ventricular dysfunction unrelated to coronary artery disease.
Purpose of the Study:
- To review current knowledge on SICM epidemiology, pathophysiology, and clinical presentation.
- To provide insights for optimizing the management of patients with SICM.
- To enhance understanding of SICM's course and implications for improved clinical outcomes.
Main Methods:
- Literature review of existing studies on sepsis-induced cardiomyopathy.
- Synthesis of epidemiological data.
- Analysis of pathophysiological mechanisms and clinical manifestations.
Main Results:
- SICM is a common, reversible condition in sepsis patients.
- It involves acute systolic and/or diastolic dysfunction of one or both ventricles.
- Current management focuses on restoring tissue perfusion.
Conclusions:
- A comprehensive understanding of SICM is crucial for effective patient management.
- Optimizing interventions based on SICM insights can improve outcomes.
- Further research into SICM's course and implications is warranted.
Abstract:
Sepsis remains the most common cause of death in critically ill patients worldwide and the most frequent non-cardiac disease diagnosed in the Coronary Care Unit. Myocardial dysfunction caused by sepsis, usually termed 'sepsis-induced cardiomyopathy' (SICM), is common and has long been a subject of interest for intensivists and cardiologists. Despite the lack of a consensus definition, SICM is widely recognized as a reversible condition characterized by acute single or bi-ventricular systolic and/or diastolic dysfunction unrelated to coronary artery disease. While indications for monitoring and treating septic cardiomyopathy are directed towards restoring tissue perfusion, a better understanding of the course and implications of septic cardiomyopathy may help to optimize interventions and improve clinical outcomes. The present review aims to summarize current knowledge on the epidemiology, pathophysiology and clinical presentation of SICM, and to provide insights to aid clinicians in managing affected patients.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Myocarditis I: Introduction
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Rheumatic Heart Disease I: Introduction

